secwatch.observer — SEC 8-K summary
======================================

Issuer:     AIM ImmunoTech Inc. (AIM)
CIK:        0000946644
Form:       8-K
Filed at:   2025-12-17T23:59:59+00:00
Accession:  0001493152-25-028156
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

AIM ImmunoTech holds 2025 annual meeting; all director nominees elected, say-on-pay advisory approved by votes cast
--------------------------------------------------------------------------------

- All five director nominees elected with majority of votes cast; broker non-votes of 833,173 on each.
- Ratification of BDO USA as auditor approved: 1,104,780 for, 29,754 against, 9,849 abstain.
- Advisory say-on-pay approved by 193,668 for vs 115,337 against, but failed due to 833,173 broker non-votes.
- Advisory vote on frequency selected 1 year (284,856 votes), consistent with board recommendation.
- Quorum of 41.4% (1,144,383 shares) present; 2,764,188 shares outstanding.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/946644/000149315225028156/0001493152-25-028156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/946644/000149315225028156/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-25-028156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer